{
    "Variants Include": [
        {
            "Gene": "a - Synuclein",
            "variants": [
                {
                    "HGVS": "N.D. (HGVS nomenclature not provided in the literature, unable to standardize without further information)",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "P",
                        "position": "30"
                    },
                    "Description in input context": "A30P"
                },
                {
                    "HGVS": "N.D. (HGVS nomenclature not provided in the literature, unable to standardize without further information)",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "T",
                        "position": "53"
                    },
                    "Description in input context": "A53T"
                },
                {
                    "HGVS": "N.D. (HGVS nomenclature not provided in the literature, unable to standardize without further information)",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "P" and "A",
                        "alt2": "T",
                        "position": "30 and 53"
                    },
                    "Description in input context": "A53T/A30P"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson's disease",
        "MONDO": "MONDO:0005149"
    },
    "Experiment Method": [
        {
            "Assay Method": "Vesicle ultracentrifugation",
            "Material used": {
                "Material Source": "Recombinant proteins and synthetic phospholipid vesicles",
                "Material Name": "Brain PE/brain PS (1:1, w/w) MLVs, wild - type a - Syn, A30P a - Syn, A53T a - Syn, A53T/A30P a - Syn",
                "Description": "Brain PE/brain PS (1:1, w/w) MLVs were mixed with either WT or A30P a - Syn at 10:1 and 20:1 mass ratios (188:1 and 376:1 molar ratios) of phospholipid to protein and incubated in PBS at 25 Â°C for one hour. For A53T and A53T/A30P, similar lipid - protein ratio mixtures were used in related binding studies. "
            },
            "Readout type": "Quantitative (protein amount in pellet and supernatant)",
            "Readout description": [
                {
                    "Variant": "A30P",
                    "Conclusion": "Abnormal (significantly impaired binding compared to WT)",
                    "Molecular Effect": "loss - of - function (defective in binding to phospholipid vesicles)",
                    "Result Description": "Barely detectable levels of A30P a - Syn were found in the membrane pellet. Doubling the concentration of MLVs as compared to a - Syn did not change the amount of A30P in the pellet. Unbound A30P a - Syn in the supernatant was higher compared to WT."
                },
                {
                    "Variant": "A53T",
                    "Conclusion": "Normal (comparable to WT in terms of membrane - binding activity)",
                    "Molecular Effect": "No Effect (in terms of membrane - binding activity)",
                    "Result Description": "A53T a - Syn displayed a normal membrane - binding activity that was comparable to wild - type a - Syn."
                },
                {
                    "Variant": "A53T/A30P",
                    "Conclusion": "Abnormal (defective in membrane binding similar to A30P)",
                    "Molecular Effect": "loss - of - function (defective in binding to phospholipid vesicles)",
                    "Result Description": "The double mutant A53T/A30P a - Syn showed defective membrane binding similar to the A30P protein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "These experiments were repeated several times to confirm their reproducibility."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D. (Based on general knowledge, normal would be similar binding as wild - type a - Syn to lipid vesicles)",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D. (Based on general knowledge, abnormal would be significantly reduced binding compared to wild - type a - Syn to lipid vesicles)",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes (Vesicle ultracentrifugation is a common method to study protein - lipid binding, which is relevant to Parkinson's disease research as it helps understand the membrane - binding properties of a - Syn mutants related to the disease)"
            }
        },
        {
            "Assay Method": "Circular dichroism spectroscopy",
            "Material used": {
                "Material Source": "Recombinant proteins and synthetic phospholipid vesicles",
                "Material Name": "POPC/bPS, bPE/bPS, POPC/POPA vesicles, wild - type a - Syn, A30P a - Syn, A53T a - Syn, A53T/A30P a - Syn",
                "Description": "a - Synuclein (0.1 - 0.2 mg/ml; 6.9 - 13.8 mM) was incorporated into MLVs (lipid concentration of 1 - 2 mg/ml; 1.3 - 2.6 mM) of various phospholipids. Samples were incubated and then used for CD measurements."
            },
            "Readout type": "Quantitative (ellipticity at 222 nm as a measure of a - helicity)",
            "Readout description": [
                {
                    "Variant": "A30P",
                    "Conclusion": "Abnormal (failed to undergo typical structural transition from random coil to a - helix like WT)",
                    "Molecular Effect": "loss - of - function (defective in binding to phospholipid vesicles)",
                    "Result Description": "CD spectra of A30P and A53T/A30P a - Syn in the presence of POPC/bPS vesicles were virtually identical with a - Syn in buffer alone. The extent of PE - induced a - helicity was much less for A30P and A53T/A30P a - Syn compared to WT or A53T a - Syn."
                },
                {
                    "Variant": "A53T",
                    "Conclusion": "Normal (underwent conformational transition from random coil to a - helix similar to WT)",
                    "Molecular Effect": "No Effect (in terms of membrane - binding - induced conformational change)",
                    "Result Description": "WT and A53T a - Syn bound to POPC/bPS vesicles and underwent a conformational transition from random coil to a - helical secondary structure, as shown by increased ellipticities."
                },
                {
                    "Variant": "A53T/A30P",
                    "Conclusion": "Abnormal (failed to undergo typical structural transition from random coil to a - helix like WT)",
                    "Molecular Effect": "loss - of - function (defective in binding to phospholipid vesicles)",
                    "Result Description": "CD spectra of A30P and A53T/A30P a - Syn in the presence of POPC/bPS vesicles were virtually identical with a - Syn in buffer alone. The extent of PE - induced a - helicity was much less for A30P and A53T/A30P a - Syn compared to WT or A53T a - Syn."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "CD values at 222 nm from three to four separate experiments were averaged and standard deviations were indicated."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Three scans per sample were averaged."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D. (Based on general knowledge, normal would be similar ellipticity changes as wild - type a - Syn indicating similar conformational transition)",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D. (Based on general knowledge, abnormal would be significantly different ellipticity changes compared to wild - type a - Syn indicating disrupted conformational transition)",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes (Circular dichroism spectroscopy is a common method to study protein secondary structure changes, which is relevant to Parkinson's disease research as it helps understand the structural changes of a - Syn mutants related to the disease)"
            }
        },
        {
            "Assay Method": "Low - angle X - ray diffraction",
            "Material used": {
                "Material Source": "Recombinant proteins and synthetic phospholipid vesicles",
                "Material Name": "bPE/POPS MLVs, wild - type a - Syn, A30P a - Syn",
                "Description": "Equimolar mixtures of bPE and POPS were dried, dispersed in buffer or a - Syn solution, vortexed, ultracentrifuged, and then dialyzed against PEG solutions. Samples were mounted for X - ray diffraction."
            },
            "Readout type": "Quantitative (repeat spacing of lipid bilayers)",
            "Readout description": [
                {
                    "Variant": "A30P",
                    "Conclusion": "Abnormal (did not significantly alter the pressure - versus - repeat distance relationship of the pure lipid bilayer like WT)",
                    "Molecular Effect": "loss - of - function (defective in binding to the lipid bilayers)",
                    "Result Description": "At low osmotic pressure (8 - 10 % PEG), A30P a - Syn did not significantly change the repeat spacing, probably due to defective binding to the lipids. With 8 % PEG, the repeat distance in the presence of A30P a - Syn (135 Ã) was very close to that in the absence of a - Syn (132 Ã). With 10 % PEG, the repeat distance was 117 Ã, which is smaller than that in the presence of WT a - Syn (127 Ã)."
                },
                {
                    "Variant": "Wild - type",
                    "Conclusion": "Normal (significantly altered the pressure - versus - repeat distance relationship of the pure lipid bilayer)",
                    "Molecular Effect": "Normal (able to interact with lipid bilayers as expected)",
                    "Result Description": "With 8 % PEG, the X - ray pattern showed disordering of the bilayer. With 10 % PEG, the repeat spacing was 127 Ã, which is significantly larger than the pure lipid (104 Ã)."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D. (Based on general knowledge, normal would be similar repeat spacing changes as wild - type a - Syn in the presence of lipid bilayers)",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D. (Based on general knowledge, abnormal would be significantly different repeat spacing changes compared to wild - type a - Syn in the presence of lipid bilayers)",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes (Low - angle X - ray diffraction is a common method to study the structure of lipid bilayers and protein - lipid interactions, which is relevant to Parkinson's disease research as it helps understand the membrane - binding properties of a - Syn mutants related to the disease)"
            }
        }
    ]
}